Veterinary Medicines

TABERNIL ANTIASMATICO

Not authorised
  • Dexamethasone sodium phosphate
  • Theophylline
  • Ephedrine hydrochloride
  • Diphenhydramine hydrochloride
Download as PDF

Product identification

Medicine name:
TABERNIL ANTIASMATICO
Active substance:
  • Dexamethasone sodium phosphate
  • Theophylline
  • Ephedrine hydrochloride
  • Diphenhydramine hydrochloride
Target species:
  • Ornamental bird
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Dexamethasone sodium phosphate
    0.04
    milligram(s)
    /
    1.00
    millilitre(s)
  • Theophylline
    4.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Ephedrine hydrochloride
    2.00
    milligram(s)
    /
    1.00
    millilitre(s)
  • Diphenhydramine hydrochloride
    0.80
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Solution for use in drinking water
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QR03CK
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Surrendered
Authorised in:
  • Spain
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Divasa Farmavic S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Divasa Farmavic S.A.
Responsible authority:
  • Spanish Agency Of Medicines And Medical Devices
Authorisation number:
  • 2066 ESP
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download

Labelling

This document does not exist in this language (English). You can find it in another language below.
Spanish (PDF)
Published on: 9/11/2022
Download